Patent ID: 8557302

Claim:
A method of treating ulcerative colitis comprising orally administering to a human in recognized need of such treatment an effective amount for treating of a solid dosage form comprising: (1) an extract of Andrographis paniculata comprising andrographolide lactones: wherein said andrographolide lactones comprise: andrographolide in an amount ranging from 6% to 20% of the dry weight of the extract; 14-deoxyandrographolide in an amount ranging from greater than 0 to less than 1% of the dry weight of the extract; 14-deoxy-11,12-dehydrogen-andrographolide in an amount ranging from 1% to 6% of the dry weight of the extract; and neoandrographolide in an amount ranging from 1% to 5% of the dry weight of the extract, and (2) wherein said solid dosage form for treating ulcerative colitis in a human further comprises at least one pharmaceutically acceptable carrier.